Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›
Research›
Non-Profits›
Arrowhead Pharmaceuticals
AddedMar 19, 2024
UpdatedJun 28, 2026
Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

Operating

Innovative biopharmaceutical company developing RNAi treatments for various diseases.

Founded
2001
Location
Pasadena, CA, US
Overview
Compare
Employees
Website

Founded in Pasadena, California, Arrowhead Pharmaceuticals is an innovative biopharmaceutical company dedicated to developing RNA interference (RNAi) treatments for various intractable diseases. Their core mission is to target and silence disease-causing genes, addressing significant unmet medical needs. Utilizing their proprietary TRiM™ platform, Arrowhead creates targeted RNAi molecules designed to leverage natural pathways for gene silencing. The company focuses on developing medicines for conditions with limited treatment options, aiming to transform patient care and outcomes.

Arrowhead Pharmaceuticals has achieved notable success, including successful topline phase results for Plozasiran in treating Familial Chylomicronemia Syndrome. The company has garnered attention from prominent investors and industry experts, contributing to its growing reputation in the biotechnology sector. Arrowhead's innovative approach and significant advancements in RNAi technology have positioned it as a key player in the development of next-generation therapeutics, making a substantial impact on the treatment landscape for genetic diseases.

Arrowhead Pharmaceuticals - Quick Facts

When was Arrowhead Pharmaceuticals founded?

Arrowhead Pharmaceuticals was founded in 2001.

Where is Arrowhead Pharmaceuticals' headquarters located?

Arrowhead Pharmaceuticals' headquarters is located in Pasadena, CA, US.

When was Arrowhead Pharmaceuticals' last funding round?

Arrowhead Pharmaceuticals' most recent funding round was for $450M (USD) in January 2024.

How much has Arrowhead Pharmaceuticals raised to-date?

As of Jan 3, 2024, Arrowhead Pharmaceuticals has raised a total of $899.9M (USD).

How many employees does Arrowhead Pharmaceuticals have?

Arrowhead Pharmaceuticals has 525 employees as of Feb 6, 2024.

Arrowhead Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
  • RNAI
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Rnai Treatments
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 38 more industry codes
NAICS
  • 334200Communications Equipment Manufacturing
  • 334210Telephone Apparatus Manufacturing
  • 334400Semiconductor and Other Electronic Component Manufacturing
  • 334418Printed Circuit Assembly (Electronic Assembly) Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541713Research and Development in Nanotechnology
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 813000Religious, Grantmaking, Civic, Professional, and Similar Organizations
  • 813100Religious Organizations
  • 813110Religious Organizations
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 810000Other Services (except Public Administration)
  • 334000Computer and Electronic Product Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 334410Semiconductor and Other Electronic Component Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 3660Communications Equipment
  • 3661Telephone And Telegraph Apparatus
  • 8600Membership Organizations
  • 8660Religious Organizations
  • 8661Religious Organizations
  • 3600Electronic And Other Electrical Equipment And Components, Except Computer
  • 4000Railroad Transportation
  • 6000Depository Institutions
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 2610Manufacture of electronic components and boards
  • 2630Manufacture of communication equipment
  • 7210Research and experimental development on natural sciences and engineering
  • 9491Activities of religious organizations